Duquesne Family Office’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.5M | Buy |
100,675
+5,845
| +6% | +$4.56M | 1.93% | 16 |
|
|
2025
Q1 | $78.3M | Buy |
94,830
+32,640
| +52% | +$27M | 2.56% | 12 |
|
|
2024
Q4 | $48M | Buy |
+62,190
| New | +$48M | 1.29% | 19 |
|
|
2024
Q2 | – | Sell |
-61,664
| Closed | -$48M | – | 76 |
|
|
2024
Q1 | $48M | Sell |
61,664
-340,886
| -85% | -$265M | 1.09% | 22 |
|
|
2023
Q4 | $235M | Sell |
402,550
-51,565
| -11% | -$30.1M | 7% | 4 |
|
|
2023
Q3 | $244M | Sell |
454,115
-82,330
| -15% | -$44.2M | 8.75% | 4 |
|
|
2023
Q2 | $252M | Sell |
536,445
-69,765
| -12% | -$32.7M | 8.75% | 4 |
|
|
2023
Q1 | $208M | Sell |
606,210
-131,515
| -18% | -$45.2M | 9.02% | 4 |
|
|
2022
Q4 | $270M | Buy |
737,725
+252,830
| +52% | +$92.5M | 13.36% | 2 |
|
|
2022
Q3 | $157M | Buy |
484,895
+187,745
| +63% | +$60.7M | 8.89% | 2 |
|
|
2022
Q2 | $96.3M | Buy |
+297,150
| New | +$96.3M | 6.97% | 4 |
|